指南与共识胸部肿瘤

泛亚版ESMO临床实践指南:局部晚期不可切除非小细胞肺癌管理

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
指南 / 共识 · Ann Oncol · 2019-12-20

该指南由ESMO与KSMO牵头,联合CSCO、ISMPO、JSMO、MOS、SSO和TOS,基于2017年ESMO指南进行泛亚适应性调整,以纳入亚洲患者在种族、肿瘤生物学及局部晚期不可切除NSCLC治疗标准实践方面的潜在差异,形成七地专家共识。投票基于科学证据,独立于各地当前治疗实践及药物可及性与报销情况。

要点

  • 基于2017年ESMO指南进行泛亚适应性调整,聚焦局部晚期不可切除NSCLC。
  • 由ESMO与KSMO牵头,七地肿瘤学会专家参与共识投票。
  • 投票基于科学证据,独立于各地治疗实践与药物可及性。

核心结论

  • 该指南代表七地肿瘤学会专家对亚洲局部晚期不可切除NSCLC管理的共识意见。

研究设计与样本

  • ESMO与KSMO牵头,联合CSCO、ISMPO、JSMO、MOS、SSO和TOS,基于2017年ESMO指南进行泛亚适应性调整,形成专家共识。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of early and locally-advanced non-small-cell lung cancer (NSCLC) was published in 2017, and covered the diagnosis, staging, management and treatment of both early stage I and II disease and locally-advanced stage III disease. At the ESMO Asia Meeting in November 2018, it was decided by both the ESMO and the Korean Society of Medical Oncology (KSMO) to convene a special face-to-face guidelines meeting in 2019 in Seoul. The aim was to adapt the ESMO 2017 guidelines to take into account potential differences related to ethnicity, cancer biology and standard practices associated with the treatment of locally-advanced, unresectable NSCLC in Asian patients. These guidelines represent the consensus opinions reached by those experts in the treatment of patients with lung cancer who represented the oncology societies of Korea (KSMO), China (CSCO), India (ISMPO), Japan (JSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence, and it was independent of both local current treatment practices and the treatment availability and reimbursement situations in the individual participating Asian countries.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Park K, Vansteenkiste J, Lee KH, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS. Ann Oncol. 2019. PMID: 31959336. doi:10.1016/j.annonc.2019.10.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。